Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
David Mountcastle is EVP & Chief Financial Officer at Privia Health Group, Inc.. OQRO lists 6 transactions filed with the SEC under this name, the latest on May 14, 2025, each linked to the official Form 4.
EVP & Chief Financial Officer
Disclosures on record
6
Companies involved
1
As of the latest filing on , David Mountcastle reported holding 172,909 shares of Privia Health Group, Inc. (PRVA), worth about $4.24M at the last close of $25 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Privia Health Group, Inc. PRVA | 172,909 | 173K direct | $25 | $4.24M | May 12, 2025 |
Is this David Mountcastle’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Privia Health Group, Inc.PRVA
6 disclosures · Feb 2025 – May 2025 · 6 sold
May 12, 2025Sold~$83Kdisclosed May 14
DetailsOfficial recordApr 30, 2025Sold~$80Kdisclosed May 2
DetailsOfficial recordApr 2, 2025Sold~$126Kdisclosed Apr 3
DetailsOfficial recordMar 10, 2025Sold~$73Kdisclosed Mar 12
DetailsOfficial recordMar 11, 2025Sold~$69Kdisclosed Mar 12
DetailsOfficial recordFeb 14, 2025Sold~$2.52Mdisclosed Feb 19
DetailsOfficial recordDavid Mountcastle has no open-market purchase on record since 2021. Sales in each of the last 5 years.
David Mountcastle reported 0 open-market purchases and 32 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $2.95M6×6 trades |
| 2024 | — | $153K3×3 trades |
| 2023 | — | $247K3×3 trades |
| 2022 | — | $4.14M17×17 trades |
| 2021 | — | $1.4M3×3 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated May 12, 2025, David Mountcastle reported holding 172,909 shares of Privia Health Group, Inc. (PRVA). At the last close of $25 on Nov 13, 2026, that is about $4.24M. This is the stake disclosed in filings, not a net worth.
David Mountcastle has no open-market purchase on record since 2021. Sales in each of the last 5 years.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2025.
Privia Health Group, Inc. (PRVA), from 2021 to 2025: 0 purchases and 32 sales.
David Mountcastle reported 0 open-market purchases and 32 sales here, 2021 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
